(Q53956450)

English

Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.

scientific article published in February 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

0 references

1 reference

based on heuristic

inferred from title

author name string

M Baulac

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

D Cavalcanti

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

F Semah

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

A Arzimanoglou

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

J J Portal

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

Seizure-European Journal of Epilepsy

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

55-62

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin as an antiepileptic drug in man

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind study of Gabapentin in the treatment of partial seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with gabapentin for partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for Classification of Epilepsies and Epileptic Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiepileptic drugs, clinical trials, and the marketplace

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1059-1311%2898%2990009-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1059-1311(98)90009-7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/9548227

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53956450&oldid=1414715216"